The new model for equitable access in LMICs - From initiative to integrated ecosystems
Published on August 27, 2025
How pharmaceutical leaders are successfully embedding equitable access into strategy, structure, and scale across LMICs
Download our white paper to discover how to build future-ready access strategies in LMICs – and elevate your role in shaping the next era of pharma leadership and global health equity.
Why it matters
With 88% of the world’s population living in LMICs, these markets are central to pharma’s future. The industry is shifting from donor-led programs to sustainable access ecosystems where equity is integrated into strategy, R&D, and commercialization. Companies that act now will unlock growth, strengthen healthcare systems, and advance global health equity.
